Horm Metab Res 2009; 41(5): 381-386
DOI: 10.1055/s-0028-1128140
Humans, Clinical

© Georg Thieme Verlag KG Stuttgart · New York

Effects of Acute Pinitol Supplementation on Plasma Pinitol Concentration, Whole Body Glucose Tolerance, and Activation of the Skeletal Muscle Insulin Receptor in Older Humans

A. J. Stull 1 [#] , K. V. Wood 2 , J. P. Thyfault 3 , W. W. Campbell 1
  • 1Department of Foods and Nutrition and Center on Aging and the Life Course, Purdue University, West Lafayette, IN, USA
  • 2Department of Chemistry, Purdue University, West Lafayette, IN, USA
  • 3Department of Nutritional Sciences and Internal Medicine and Harry S. Truman VA Hospital, University of Missouri, Columbia, MO, USA
Weitere Informationen

Publikationsverlauf

received 08.07.2008

accepted 04.12.2008

Publikationsdatum:
16. Februar 2009 (online)

Abstract

Limited research with rodents and humans suggests that oral ingestion of pinitol (3-O-methyl-D-chiro-inositol) might positively influence glucose tolerance. This double-blinded, placebo-controlled, and cross-over study assessed the effects of acute pinitol supplementation on plasma pinitol concentration, glucose tolerance, insulin sensitivity, and activation of the skeletal muscle insulin receptor. Fifteen older, nondiabetic subjects (62±1 years, mean±SEM) completed four, 1-day trials. Subjects consumed a non-nutritive beverage with nothing (placebo) or 1 000 mg pinitol. Sixty minutes later, the subjects consumed beverages that were either energy- and carbohydrate-free (Sham) or contained 75 g glucose (OGTT). Blood samples were collected frequently over the 240-min testing period. For the OGTT trials only, vastus lateralis samples were obtained before the placebo and pinitol supplementation and 60 min after consuming the 75 g glucose beverage. Plasma pinitol concentration increased and was maintained for 240 min. Pinitol did not influence the fasting state and 180-min area under the curves for plasma glucose and insulin during the Sham and OGTT trials or hepatic (placebo 0.83±0.08; pinitol 0.80±0.08) and whole-body (placebo 6.10±0.54; pinitol 6.22±0.52) insulin sensitivities. Activation of the muscle insulin receptor was increased by 140% with glucose ingestion (Pre 0.62±0.12; Post 1.49±0.35), but pinitol did not influence this response. These results show that the pinitol supplement was quickly absorbed, but did not acutely influence indices of whole-body glucose tolerance and insulin sensitivity, or the activation of the skeletal muscle insulin receptor in older, nondiabetic humans.

References

  • 1 DeFronzo RA. Glucose intolerance and aging.  Diabetes Care. 1981;  4 493-501
  • 2 Larner J. D-chiro-inositol – its functional role in insulin action and its deficit in insulin resistance.  Int J Exp Diabetes Res. 2002;  3 47-60
  • 3 Larner J, Huang LC, Schwartz CF, Oswald AS, Shen TY, Kinter M, Tang GZ, Zeller K. Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphate contains galactosamine and D-chiroinositol.  Biochem Biophys Res Commun. 1988;  151 1416-1426
  • 4 Ortmeyer HK, Bodkin NL, Hansen BC, Larner J. In vivo D-chiroinositol activates skeletal muscle glycogen synthase and inactivates glycogen phosphorylase in rhesus monkeys.  Nutr Biochem. 1995;  6 499-503
  • 5 Saltiel AR. Second messengers of insulin action.  Diabetes Care. 1990;  13 244-256
  • 6 Phillips DV, Dougherty DE, Smilth AE. Cyclitols in soybean.  J Agric Food Chem. 1982;  30 456-458
  • 7 Streeter JG, Strimbu CE. Simultaneous extraction and derivatization of carbohydrates from green plant tissues for analysis by gas-liquid chromatography.  Anal Biochem. 1998;  259 253-257
  • 8 Bates SH, Jones RB, Bailey CJ. Insulin-like effect of pinitol.  Br J Pharmacol. 2000;  130 1944-1948
  • 9 Narayanan CR. Pinitol – A new anti-diabetic compound from the leaves of Bougainvillea Spectabilis.  Curr Sci. 1987;  56 139-141
  • 10 Kang MJ, Kim JI, Yoon SY, Kim JC, Cha IJ. Pinitol from soybeans reduces postprandial blood glucose in patients with type 2 diabetes mellitus.  J Med Food. 2006;  9 182-186
  • 11 Kim JI, Kim JC, Kang MJ, Lee MS, Kim JJ, Cha IJ. Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study.  Eur J Clin Nutr. 2005;  59 456-458
  • 12 Kim MJ, Yoo KH, Kim JH, Seo YT, Ha BW, Kho JH, Shin YG, Chung CH. Effect of pinitol on glucose metabolism and adipocytokines in uncontrolled type 2 diabetes.  Diabetes Res Clin Pract. 2007;  77 ((Suppl 1)) S247-S251
  • 13 Campbell WW, Haub MD, Fluckey JD, Ostlund Jr RE, Thyfault JP, Morse-Carrithers H, Hulver MW, Birge ZK. Pinitol supplementation does not affect insulin-mediated glucose metabolism and muscle insulin receptor content and phosphorylation in older humans.  J Nutr. 2004;  134 2998-3003
  • 14 Davis A, Christiansen M, Horowitz JF, Klein S, Hellerstein MK, Ostlund Jr RE. Effect of pinitol treatment on insulin action in subjects with insulin resistance.  Diabetes Care. 2000;  23 1000-1005
  • 15 Harris JA, Benedict FG. A biometric study of basal metabolism in man. Carnegie Institute of Washington, Washington D. C. 1919
  • 16 Shetty PS, Henry CJ, Black AE, Prentice AM. Energy requirements of adults: an update on basal metabolic rates (BMRs) and physical activity levels (PALs).  Eur J Clin Nutr. 1996;  50 ((Suppl 1)) S11-S23
  • 17 Evans WJ, Phinney SD, Young VR. Suction applied to a muscle biopsy maximizes sample size.  Med Sci Sports Exerc. 1982;  14 101-102
  • 18 Campbell WW, Ostlund Jr RE, Joseph LJ, Farrell PA, Evans WJ. Relationships of plasma C-peptide and gender to the urinary excretion of inositols in older people.  Horm Metab Res. 2001;  33 44-51
  • 19 Wolever TM, Jenkins DJ. The use of the glycemic index in predicting the blood glucose response to mixed meals.  Am J Clin Nutr. 1986;  43 167-172
  • 20 Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.  Diabetes Care. 1999;  22 1462-1470
  • 21 Ostlund RE Jr, MacGill JB, Herskowitz I, Kipnis DM, Santiago JV, Sherman WR. D-chiro-inositol metabolism in diabetes mellitus.  Proc Natl Acad Sci USA. 1993;  90 9988-9992
  • 22 Thyfault JP, Cree MG, Zheng D, Zwetsloot JJ, Tapscott EB, Koves TR, Ilkayeva O, Wolfe RR, Muoio DM, Dohm GL. Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism.  Am J Physiol Cell Physiol. 2007;  292 C729-C739
  • 23 MacCrory MA, Gomez TD, Bernauer EM, Mole PA. Evaluation of a new air displacement plethysmograph for measuring human body composition.  Med Sci Sports Exerc. 1995;  27 1686-1691
  • 24 Siri W. Body Composition from fluid spaces and density: analysis of methods. Techniques for measuring body composition. Washington, D.C.: National Academy of Sciences 1961: 223-224
  • 25 Baillargeon JP, Iuorno MJ, Jakubowicz DJ, Apridonidze T, He N, Nestler JE. Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome.  J Clin Endocrinol Metab. 2004;  89 242-249
  • 26 Sarashina G, Yamakoshi M, Noritake M, Takahashi M, Kure M, Katsura Y, Shiomi H, Tsuboi I, Kawazu S, Yamagata F, Tominaga M, Matsuoka T. A study of urinary myo-inositol as a sensitive marker of glucose intolerance.  Clin Chim Acta. 2004;  344 181-188

1 During the time the research was conducted Dr. April J. Stull was a doctoral student and currently she is a postdoctoral fellow at Pennington Biomedical Research Center, Division of Nutrition and Chronic Disease and Botanicals Research Center, 6400 Perkins Rd., Baton Rouge, LA 70808, USA

Correspondence

W. W. CampbellPhD 

Department of Foods and Nutrition

Purdue University

700 West State Street

West Lafayette

IN 47907-2059

USA

Telefon: +1/765/494 82 36

Fax: +1/765/494 06 74

eMail: campbellw@purdue.edu

    >